Bodewell

Bodewell sells steroid-free, plant-based creams, cleansers and moisturizers for eczema, psoriasis and severely dry skin; all items are priced mid-range ($14-$34 per 4-8 oz tube/jar). The line is concentrated on three regimens—Daily Eczema, Psoriasis Calming and Sensitive Body Care—and is sold direct-to-consumer through bodewell.com and Amazon, with no brick-and-mortar distribution. The brand’s hook is “B7,” a patented blend of seven botanical actives (colloidal oatmeal, shea, madecassoside, etc.) shown in third-party trials to reduce itching and flare frequency without corticosteroids. Every formula is fragrance-free, National Eczema Association–accepted and packaged in sugar-cane-derived tubes, positioning Bodewell as clinical-grade relief that is still clean and sustainable. Core buyers are adults 25-45 managing chronic flare-ups who want Rx-level results but avoid steroids, parabens and synthetic fragrance; parents of eczema-prone toddlers are a fast-growing subset. The brand speaks to values of skin-barrier science, ingredient transparency and low-waste living, offering subscription bundles and a 60-day “Calm Skin” guarantee. Bodewell competes in the crowded “derma-care” segment against legacy pharmacy ointments, prescription topicals and upscale clean-body brands; it differentiates by bridging efficacy and clean positioning—delivering clinically tested botanical formulas at half the price of prestige derm brands while remaining gentler and more sustainable than traditional OTC steroid creams.